Arena's other shoe

Arena: Rat brain data doesn't address breast cancer concerns for obesity drug

Arena's other shoe

Arena Pharmaceuticals Inc. (NASDAQ:ARNA) allayed some concerns last week over the carcinogenicity of its lorcaserin obesity candidate, but investors are likely to remain on edge until data addressing an increased rate of mammary tumors in female rats

Read the full 399 word article

How to gain access

Continue reading with a
two-week free trial.